Effects of the Prior Use of Statins on Head and Neck Cancer Risk: A Hospital-Based Case-Control Study.

Saka-Herrán, Constanza; Jané-Salas, Enric; Mano-Azul, Antonio; Torrejón-Moya, Aina; Estrugo-Devesa, Albert; López-López, José

Saka-Herrán, Constanza; Jané-Salas, Enric; Mano-Azul, Antonio; Torrejón-Moya, Aina; Estrugo-Devesa, Albert; López-López, José.

Afiliación

Saka-Herrán C; Department of Odontostomatology, Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona, 08970 Barcelona, Spain.
Jané-Salas E; Department of Odontostomatology, Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona, 08970 Barcelona, Spain.
Mano-Azul A; Oral Health and Masticatory System Group (Bellvitge Biomedical Research Institute) IDIBELL, Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona, 08970 Barcelona, Spain.
Torrejón-Moya A; Department of Oral Surgery, Oral Medicine, and Maxillofacial Surgery, Egas Moniz Higher Education School, Campus Universitario, Quinta da Granja, 2829-511 Caparica, Portugal.
Estrugo-Devesa A; Department of Odontostomatology, Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona, 08970 Barcelona, Spain.
López-López J; Department of Odontostomatology, Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona, 08970 Barcelona, Spain.

Pharmaceuticals (Basel) ; 15(5)2022 May 06.

Article en En | MEDLINE | ID: mdl-35631405

Palabras clave

cancer; head and neck cancer; head and neck neoplasms; hydroxymethilglutaryl-CoA reductase inhibitors; risk; statins

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google